James Wilson is the director of the Gene Therapy Program at the University of Pennsylvania. He is also a founder and chief scientific advisor at RegenxBio, as well as founder and chairman of the scientific advisory council at Dimension Therapeutics. Wilson's conversation covers his love of motocross racing, the triumphs and tribulation of gene therapy (including the Jesse Gelsinger tragedy) and the future of drug pricing.
Rights and permissions
About this article
Cite this article
First Rounders Podcast: James Wilson. Nat Biotechnol 34, 11 (2016). https://doi.org/10.1038/nbt.3457
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3457